PRPO — Precipio, Inc.
$22.13
$-1.12 (-4.82%)
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Market Cap
$39.68M
Forward P/E
56.7x
52-Week Range
N/A
PRPO Price History
Revenue vs. Net Income
$9.4M
Revenue · FY2022
Annual. Net margin is shown under each year.
Free Cash Flow
-$8M
FCF · FY2022
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
-71.0%
ROCE · FY2022
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
4.1x
Assets ÷ liabilities · FY2022
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
2.9%
CapEx · FY2022
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
1.1M
Diluted shares · FY2022
Only one year of share data is available, so no change can be shown yet.
